GILOTRIF (afatinib) for Non-small Cell Lung Cancer - Cancer Therapy Advisor

GILOTRIF (afatinib) for Non-small Cell Lung Cancer

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for GILOTRIF (afatinib), indicated for non-small cell lung cancer.

Table of Contents

Slide 2: Indication, Dosage, and Administration
Slide 9: Use in Specific Populations
Slide 12: Clinical Pharmacology
Slide 16: Warnings and Precautions
Slide 21: Clinical Safety and Efficacy
Slide 31: Drug Storage and Supply
Slide 34: References

Next hm-slideshow in Lung Cancer